Flerie AB (publ) FLERIE

Updated: 11 Aug 2026

NASDAQ | Finance | Life science investment company

No signal published yet

We already track Flerie and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Flerie free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Finance
Sector
Life science investment company
We're already tracking Flerie AB (publ) — here are the latest events we've registered

Recent News

  • On August 6, 2026, an extraordinary general meeting in Flerie approved the merger plan with Biosergen AB, representing the company's first new investment since listing on Nasdaq Stockholm. Under the absorption agreement, 31 shares in Biosergen will be exchanged for one new ordinary share in Flerie. The merger is expected to be registered with the Swedish Companies Registration Office during the fourth quarter of 2026.

What Firelda Watch includes for Flerie AB (publ)

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Flerie AB (publ) will be delivered in the same format.

Want to follow Flerie AB (publ)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Flerie free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Flerie AB (publ) FLERIE
Flerie — follow and we'll monitor it
Follow Flerie free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.